Evidence map›Paper›PMID 22125569›Full record

ArticleDrug discovery today. Disease models2011

Mast Cell Proteases and Inflammation.

Hongyan Dai, Ronald J Korthuis

Open access · greenAbstract read
In one paragraph

Article in Drug discovery today. Disease models, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. TGFCells · 2023
    Article
  10. Article
  11. Frontiers in cellular and infection microbiology · 2023
    Article
  12. Review
  13. Article
  14. Digestive Inflammation: Role of Proteolytic Dysregulation.International journal of molecular sciences · 2021
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Beneficial Effects of Neurotensin in Murine Model of Hapten-Induced Asthma.International journal of molecular sciences · 2019
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hongyan DaiDepartment of Medical Pharmacology and Physiology and Dalton Cardiovascular Research Center, University of Missouri, School of Medicine, Columbia, Missouri 65212.
Ronald J Korthuis
University of Missouri · US

Funding

Regulation Microvascular: Smooth Muscle Contraction ECM-Integrin-CytoskeletalP01HL095486 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MEININGER, GERALD A. · 2010 to 2014
$8.4M
Ethanol Prevents Microvascular DysfunctionR01AA014945 · NIAAA · UNIVERSITY OF MISSOURI-COLUMBIA · PI KORTHUIS, RONALD JOHN · 2006 to 2010
$1.6M
Venular leukocyte adhesion, impaired arteriolar vasoreactivity, and intestinal IRR01HL082816 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI KORTHUIS, RONALD JOHN · 2007 to 2010
$1.5M
NHLBI NIH HHS P01 HL095486NHLBI NIH HHS R01 HL082816NIAAA NIH HHS R01 AA014945
6 · The paper itself

Abstract

Mast cells are best known for their role in allergic reactions but are also now recognized for their important contributions to a number of disparate inflammatory conditions through the release of inflammatory mediators, serglycin and other proteoglycans, and proteases. Because these tissue resident inflammatory cells express proteases in such great abundance and their enzymatic activity results in cleavage of a multitude of proteins and peptides, which in turn modify tissue function, their substrate specificity, tissue distribution, and mode of action have become the subjects of great interest. Although mast cell protease-dependent proteolysis is critical to host defense against invading pathogens, regulation of these hydrolytic enzymes is essential to limiting self-induced damage as well. Indeed, dysregulated release of mast cell proteases is now recognized to contribute to the pathogenesis of a number of inflammatory conditions including asthma, abdominal aortic aneurysm formation, vessel damage in atherosclerosis and hypertension, arthritis, and ischemia/reperfusion injury. Understanding how mast cell proteases contribute to inflammation will thus help unravel molecular mechanisms that underlie such immunologic disorders and will help identify new therapeutic targets for drug development.

Identifiers

PMID22125569
PMCPMC3223931
OpenAlexW2079838347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.